Fig. 1
From: CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
Expression of CD44 in cancer. A The TIMER database was used to explore the expression of CD44 in many different cancers. B The differential expression of CD44 across cancers was analysed using the GEPIA2 database. C Comparison of CD44 expression in normal (n = 32) and tumour (n = 373) tissues in the TCGA database. D–E In the GEO database, CD44 expression levels in 134 and 10 pairs of gastric adenocarcinoma and normal glands were compared. ****P < 0.0001; *P < 0.05. F qRT‒PCR analysis of the relative mRNA expression levels of CD44 in GES-1 normal gastric epithelial cells and 2 types of gastric cancer cells (*P < 0.05). G In the HPA database, CAB000316 antibodies were used to detect the dye expression of CD44 protein in gastric cancer patients and normal controls